Effect of Testosterone in Men With Erectile Dysfunction

PHASE4CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
Erectile DysfunctionTestosterone DeficiencyDiabetes
Interventions
DRUG

Sildenafil citrate (open label)

On demand use of sildenafil citrate (3 tablets per week). Starting dose of 50 mg. Titrated to 100 mg or 25 mg depending on efficacy and tolerability. Begins as open label run in period for 3 - 6 weeks, and continues during the placebo-controlled testosterone gel intervention for 16 weeks.

DRUG

Testosterone gel

Testosterone Gel 1%: Starting active dose 10 g/day. Increased to 15 g/day or decreased to 5 g/day in order to attain morning total testosterone level between 500 - 1000 ng/dL. Blinding achieved by combining a total of 3 tubes of active or placebo gel, applied to upper arms and shoulders each day.

OTHER

Placebo gel

3 tubes of placebo gel equivalent to the amount of the testosterone gel will be applied during the placebo-controlled testosterone gel intervention for 16 weeks..

Trial Locations (1)

02118

Boston University Medical Center, Boston

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Boston University

OTHER

NCT00512707 - Effect of Testosterone in Men With Erectile Dysfunction | Biotech Hunter | Biotech Hunter